logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9526718 B1

PDFFull Text
Date of Patent:
Dec. 27, 2016

Filed:

Jun. 28, 2012

Combination of effective substances causing synergistic effects of multiple targeting and use thereof

Applicants:

Doo Hyun Lee, Seoul, KR;

Sunyoung Cho, Gyeonggi-do, KR;

Inventors:

Doo Hyun Lee, Seoul, KR;

Sunyoung Cho, Gyeonggi-do, KR;

Assignee:

VIVOZON, INC., Seoul, KR;

Attorneys:

Hultquist, PLLC

Steven J. Hultquist

Primary Examiner:

Qiuwen Mi

Int. Cl.
CPC ...
A61K 36/00 (2006.01); A61K 31/445 (2006.01); A61Q 19/00 (2006.01); A61K 45/06 (2006.01); A61K 8/41 (2006.01); A61K 8/49 (2006.01); A61K 31/166 (2006.01); A61K 31/198 (2006.01); A61K 31/505 (2006.01); A61K 36/884 (2006.01); A61K 36/38 (2006.01); A61K 36/69 (2006.01); A61K 36/744 (2006.01); A61K 36/40 (2006.01);
U.S. Cl.
CPC ...
A61K 31/445 (2013.01); A23L 33/10 (2016.08); A61K 8/41 (2013.01); A61K 8/4953 (2013.01); A61K 31/166 (2013.01); A61K 31/198 (2013.01); A61K 31/505 (2013.01); A61K 36/38 (2013.01); A61K 36/40 (2013.01); A61K 36/69 (2013.01); A61K 36/744 (2013.01); A61K 36/884 (2013.01); A61K 45/06 (2013.01); A61Q 19/00 (2013.01); A61K 2800/10 (2013.01);
Abstract

Disclosed are a combination of active components inducing synergistic effects of multi-targeting and a use thereof. More particularly, disclosed are a functional food composition, a cosmetic composition, a pain-suppressive composition, and a composition for treatment or prevention of pruritus or atopic dermatitis, which comprise as active components, two or more components selected from a group consisting of (a) a 5-hydroxytryptamine subtype 2 (5-HT2) receptor antagonist; (b) a P2X receptor antagonist; and (c) any one of a glycine receptor agonist, a glycine transporter (GlyT) antagonist, a gamma-aminobutyric acid (GABA) receptor agonist, and a GABA transporter 1 (GAT1) antagonist.

Find Patent Forward Citations

Loading…